1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66. PMID:
17237035.
2. Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH. Chordoma: the nonsarcoma primary bone tumor. Oncologist 2007;12:1344–1350. PMID:
18055855.
3. Hanna SA, Aston WJ, Briggs TW, Cannon SR, Saifuddin A. Sacral chordoma: can local recurrence after sacrectomy be predicted? Clin Orthop Relat Res 2008;466:2217–2223. PMID:
18584264.
4. Ruggieri P, Angelini A, Ussia G, Montalti M, Mercuri M. Surgical margins and local control in resection of sacral chordomas. Clin Orthop Relat Res 2010;468:2939–2947. PMID:
20635173.
5. Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, et al. Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 2003;10:291–296. PMID:
12679315.
6. Jawad MU, Scully SP. Surgery significantly improves survival in patients with chordoma. Spine (Phila Pa 1976) 2010;35:117–123. PMID:
20042964.
7. Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg Am 2005;87:2211–2216. PMID:
16203885.
8. Hulen CA, Temple HT, Fox WP, Sama AA, Green BA, Eismont FJ. Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg Am 2006;88:1532–1539. PMID:
16818979.
9. Higinbotham NL, Phillips RF, Farr HW, Hustu HO. Chordoma. Thirty-five-year study at Memorial Hospital. Cancer 1967;20:1841–1850. PMID:
6061621.
10. Chambers PW, Schwinn CP. Chordoma: a clinicopathologic study of metastasis. Am J Clin Pathol 1979;72:765–776. PMID:
389031.
11. Moojen WA, Vleggeert-Lankamp CL, Krol AD, Dijkstra SP. Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable. Spine (Phila Pa 1976) 2011;36:E656–E661. PMID:
21217422.
12. Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, et al. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer 2010;10:22PMID:
20109225.
13. Chen KW, Yang HL, Lu J, Liu JY, Chen XQ. Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients. Spinal Cord 2010;48:166–171. PMID:
19621022.
14. Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson RC Jr. Lumbosacral chordoma. Prognostic factors and treatment. Spine (Phila Pa 1976) 1999;24:1639–1645. PMID:
10472097.
15. Zabel-du Bois A, Nikoghosyan A, Schwahofer A, Huber P, Schlegel W, Debus J, et al. Intensity modulated radiotherapy in the management of sacral chordoma in primary versus recurrent disease. Radiother Oncol 2010;97:408–412. PMID:
21056488.
16. Fleming ID, Cooper JS, Jenson DE, Hutter RV, Kennedy BJ, Murphy GP, et al. American Joint Committee on Cancer manual for staging of cancer. 5th ed. Philadelphia: J.B. Lippincott; 1997.
17. Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 2000;88:2122–2134. PMID:
10813725.
18. Boriani S, Bandiera S, Biagini R, Bacchini P, Boriani L, Cappuccio M, et al. Chordoma of the mobile spine: fifty years of experience. Spine (Phila Pa 1976) 2006;31:493–503. PMID:
16481964.
19. Osaka S, Kodoh O, Sugita H, Osaka E, Yoshida Y, Ryu J. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol 2006;132:213–218. PMID:
16362333.
20. Dahan H, Arrive L, Wendum D, Docou le, Djouhri H, Tubiana JM. Retrorectal developmental cysts in adults: clinical and radiologic-histopathologic review, differential diagnosis, and treatment. Radiographics 2001;21:575–584. PMID:
11353107.
21. Williams LS, Rojiani AM, Quisling RG, Mickle JP. Retrorectal cyst-hamartomas and sacral dysplasia: MR appearance. AJNR Am J Neuroradiol 1998;19:1043–1045. PMID:
9672009.
22. Lim KE, Hsu WC, Wang CR. Tailgut cyst with malignancy: MR imaging findings. AJR Am J Roentgenol 1998;170:1488–1490. PMID:
9609159.
23. Llauger J, Palmer J, Amores S, Bague S, Camins A. Primary tumors of the sacrum: diagnostic imaging. AJR Am J Roentgenol 2000;174:417–424. PMID:
10658718.
24. Atalar H, Selek H, Yildiz Y, Saglik Y. Management of sacrococcygeal chordomas. Int Orthop 2006;30:514–518. PMID:
16552577.
25. Devin C, Chong PY, Holt GE, Feurer I, Gonzalez A, Merchant N, et al. Level-adjusted perioperative risk of sacral amputations. J Surg Oncol 2006;94:203–211. PMID:
16900511.
26. Samson IR, Springfield DS, Suit HD, Mankin HJ. Operative treatment of sacrococcygeal chordoma: a review of twenty-one cases. J Bone Joint Surg Am 1993;75:1476–1484. PMID:
8408136.
27. Stener B, Gunterberg B. High amputation of the sacrum for extirpation of tumors. Principles and technique. Spine (Phila Pa 1976) 1978;3:351–366. Erratum in: Rev Chir Orthop 1987;73:following 217. PMID:
741243.
28. Hsieh PC, Xu R, Sciubba DM, McGirt MJ, Nelson C, Witham TF, et al. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine (Phila Pa 1976) 2009;34:2233–2239. PMID:
19752710.
29. Guo Y, Palmer JL, Shen L, Kaur G, Willey J, Zhang T, et al. Bowel and bladder continence, wound healing, and functional outcomes in patients who underwent sacrectomy. J Neurosurg Spine 2005;3:106–110. PMID:
16370299.
30. Sciubba DM, Nelson C, Gok B, McGirt MJ, McLoughlin GS, Noggle JC, et al. Evaluation of factors associated with postoperative infection following sacral tumor resection. J Neurosurg Spine 2008;9:593–599. PMID:
19035755.
31. Chen KW, Yang HL, Lu J, Wang GL, Ji YM, Bao ZH, et al. Risk factors for postoperative wound infections of sacral chordoma after surgical excision. J Spinal Disord Tech 2011;24:230–234. PMID:
20634724.
32. Catton C, O'Sullivan B, Bell R, Laperriere N, Cummings B, Fornasier V, et al. Chordoma: long-term follow-up after radical photon irradiation. Radiother Oncol 1996;41:67–72. PMID:
8961370.
33. Cummings BJ, Hodson DI, Bush RS. Chordoma: the results of megavoltage radiation therapy. Int J Radiat Oncol Biol Phys 1983;9:633–642. PMID:
6406404.
34. Noel G, Feuvret L, Calugaru V, Dhermain F, Mammar H, Haie-Meder C, et al. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 2005;44:700–708. PMID:
16227160.
35. Van De Voorde L, Delrue L, van Eijkeren M, De Meerleer G. Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer 2011;117:4355–4364. PMID:
21446048.
36. Al-Absi E, Farrokhyar F, Sharma R, Whelan K, Corbett T, Patel M, et al. A systematic review and meta-analysis of oncologic outcomes of pre-versus postoperative radiation in localized resectable soft-tissue sarcoma. Ann Surg Oncol 2010;17:1367–1374. PMID:
20217260.
37. Casali PG, Stacchiotti S, Grosso F, Messina A, Crippa F, Tamborini E, et al. Adding cisplatin (CDDP) to imatinib (IM) re-estabishes tumor response following secondary resistance to IM in advanced chordoma [abstract]. J Clin Oncol 2007;25(18S): Abstract no. 10038.
38. Mancini M, Corradi V, Petta S, Martinelli G, Barbieri E, Santucci MA. mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein. Leuk Res 2010;34:641–648. PMID:
19643477.
39. Stacchiotti S, Longhi A, Ferraresi V, Grignani G, Comandone A, Stupp R, et al. Phase II study of imatinib in advanced chordoma. J Clin Oncol 2012;30:914–920. PMID:
22331945.
40. Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, et al. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Clin Cancer Res 2006;12:6920–6928. PMID:
17145809.
41. Marcove RC, Miller TR, Cahan WC. The treatment of primary and metastaticbone tumors by repetitive freezing. Bull N Y Acad Med 1968;44:532–544. PMID:
5239935.
42. Kollender Y, Meller I, Bickels J, Flusser G, Issakov J, Merimsky O, et al. Role of adjuvant cryosurgery in intralesional treatment of sacral tumors. Cancer 2003;97:2830–2838. PMID:
12767097.
43. Miles WK, Chang DW, Kroll SS, Miller MJ, Langstein HN, Reece GP, et al. Reconstruction of large sacral defects following total sacrectomy. Plast Reconstr Surg 2000;105:2387–2394. PMID:
10845291.
44. Chen TH. Bilateral gluteus maximus V-Y advancement musculocutaneous flaps for the coverage of large sacral pressure sores: revisit and refinement. Ann Plast Surg 1995;35:492–497. PMID:
8579267.
45. Erba P, di Summa PG, Raffoul W, Schaefer DJ, Kalbermatten DF. Tip anchor flap in decubital surgery. Aesthetic Plast Surg 2011;35:1133–1136. PMID:
21512868.
46. Tobin GR, Day TG. Vaginal and pelvic reconstruction with distally based rectus abdominis myocutaneous flaps. Plast Reconstr Surg 1988;81:62–73. PMID:
2962215.
47. Baumann DP, Butler CE. Component separation improves outcomes in VRAM flap donor sites with excessive fascial tension. Plast Reconstr Surg 2010;126:1573–1580. PMID:
20639803.
48. Buchel EW, Finical S, Johnson C. Pelvic reconstruction using vertical rectus abdominis musculocutaneous flaps. Ann Plast Surg 2004;52:22–26. PMID:
14676694.
49. Ng RW, Chan JY, Mok V, Li GK. Clinical use of a pedicled anterolateral thigh flap. J Plast Reconstr Aesthet Surg 2008;61:158–164. PMID:
18023266.
50. Chen SY, Fu JP, Chen TM, Chen SG. Reconstruction of scrotal and perineal defects in Fournier's gangrene. J Plast Reconstr Aesthet Surg 2011;64:528–534. PMID:
20797927.
51. Musculoskeletal Tumor Society. Staging of musculoskeletal neoplasms. Skeletal Radiol 1985;13:183–194. PMID:
3992263.
52. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002;94:2511–2516. PMID:
12015777.
53. Ahmed AR. Safety margins in resection of sacral chordoma: analysis of 18 patients. Arch Orthop Trauma Surg 2009;129:483–487. PMID:
18568352.
54. Schwab JH, Healey JH, Rose P, Casas-Ganem J, Boland PJ. The surgical management of sacral chordomas. Spine (Phila Pa 1976) 2009;34:2700–2704. PMID:
19910774.
55. Asavamongkolkul A, Waikakul S. Wide resection of sacral chordoma via a posterior approach. Int Orthop 2012;36:607–612. PMID:
22038441.